These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 13775667)

  • 1. Laboratory and clinical effects of nortestosterone. II. The endometrial response.
    TAYMOR ML
    Am J Obstet Gynecol; 1961 Jan; 81():95-101. PubMed ID: 13775667
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and laboratory effects of nortestosterone. I. The management of anovulatory dysfunctional uterine bleeding.
    TAYMOR ML; STURGIS SH
    Am J Obstet Gynecol; 1960 Feb; 79():316-20. PubMed ID: 13837221
    [No Abstract]   [Full Text] [Related]  

  • 3. [Observations on the clinical effects and effects on the nitrogen balance of 4-chloro-19-nortestosterone].
    LAMPERI S; BRUNO GC
    Gazz Med Ital; 1959 Dec; 118():511-7. PubMed ID: 14413700
    [No Abstract]   [Full Text] [Related]  

  • 4. [The action of 17-methyl-19-nortestosterone and of 17-ethinyl-19-nortestosterone on ovulation and on the endocrine system of the axolot].
    LEGHISSA S; FIUME ML; MATSCHER R
    Riv Biol; 1959; 51():383-99. PubMed ID: 14415318
    [No Abstract]   [Full Text] [Related]  

  • 5. On the anticatabolic and anticalcinotic effects of 17-ethyl-19-nortestosterone.
    SELYE H; RENAUD S
    Am J Med Sci; 1958 Jan; 235(1):1-6. PubMed ID: 13487581
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study of the anabolic action of 19-nortestosterone phenylpropionate. Preliminary note].
    de SALCEDO ; BORGES F; GODINHO P
    J Med (Oporto); 1960 Nov; 43():599-600. PubMed ID: 13831238
    [No Abstract]   [Full Text] [Related]  

  • 7. Endocrinologic and metabolic effects of 17 alpha-methyl-19-nortestosterone in women.
    FELDMAN EB; CARTER AC
    J Clin Endocrinol Metab; 1960 Jun; 20():842-57. PubMed ID: 13822027
    [No Abstract]   [Full Text] [Related]  

  • 8. The myotrophic and androgenic effects of 17-ethyl-19-nortestosterone and related compounds.
    SAUNDERS FJ; DRILL VA
    Endocrinology; 1956 May; 58(5):567-72. PubMed ID: 13317831
    [No Abstract]   [Full Text] [Related]  

  • 9. [On some new water-soluble derivatives of 19-nortestosterone].
    GIANNINI M; FEDI M
    Boll Chim Farm; 1960 Jan; 99():24-6. PubMed ID: 13827850
    [No Abstract]   [Full Text] [Related]  

  • 10. [Progestational activity and clinical uses of 17-vinyl-19-nortestosterone].
    MARTINEZ MANAUTOU J
    Dia Med; 1960 Feb; 32():171-8. PubMed ID: 14421804
    [No Abstract]   [Full Text] [Related]  

  • 11. Paradoxical response of metastatic breast cancer to 17-ethyl-19-nortestosterone.
    EMERSON K; MULLER J; de SOUZA ; LOUTFI G
    Ann Intern Med; 1961 Nov; 55():742-8. PubMed ID: 13890104
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the nephrotrophic action of several 19-nortestosterone derivatives].
    LOMONACO F
    Sperimentale; 1960; 110():220-30. PubMed ID: 13763286
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative pharmacological and clinical activity of 19-nortestosterone and 17-hydroxyprogesterone derivatives in man.
    EPSTEIN JA; KUPPERMANN HS; CUTLER A
    Ann N Y Acad Sci; 1958 Jul; 71(5):560-7. PubMed ID: 13583812
    [No Abstract]   [Full Text] [Related]  

  • 14. Urinary metabolites of administered 19-nortestosterone.
    ENGEL LL; ALEXANDER J; WHEELER M
    J Biol Chem; 1958 Mar; 231(1):159-64. PubMed ID: 13538956
    [No Abstract]   [Full Text] [Related]  

  • 15. [The use of 19-nortestosterone propionate in pulmonary tuberculosis].
    MIGLIOLI S; D'ERCOLE R
    Policlinico Prat; 1960 Mar; 67():385-7. PubMed ID: 13853952
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of anorexia nervosa by ethyl-nortestosterone.
    CHALMERS TM; KEKWICK A; PAWAN GL
    Proc R Soc Med; 1959 Jul; 52():514-5. PubMed ID: 13809044
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the use of ethinyl-nortestosterone acetate].
    HERRMANN U; BERGEMANN E; ARNOLD M
    Gynaecologia; 1959 Nov; 148():334-40. PubMed ID: 14401378
    [No Abstract]   [Full Text] [Related]  

  • 18. The suppression of adrenocortical secretion with 17 alpha-ethyl-19-nortestosterone.
    BROOKS RB; PRUNTY FT
    J Endocrinol; 1957 Sep; 15(4):385-92. PubMed ID: 13475598
    [No Abstract]   [Full Text] [Related]  

  • 19. Counteraction between estrogenic and progestational properties of 17 alpha-ethinyl-19-nortestosterone.
    MAEKAWA K
    Endocrinol Jpn; 1959 Sep; 6():161-5. PubMed ID: 14419722
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on anabolic agents. I. Comparative study of the anabolic action of methandrostenolone (MA) and of 19-nortestosterone phenylpropionate (NTP) in the same individuals. II. Anabolic action of a depot form of methandrostenolone].
    de SALCEDO ; SOUSA CG
    J Med (Oporto); 1962 Apr; 47():979-82. PubMed ID: 14496307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.